In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.

---

CHECK OUT OUR SPONSOR

Veracyte
https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors cover noteworthy topics, including the effectiveness of early screening and treatment for high-risk prostate cancer patients, innovative approaches in imaging and biomarkers, and the impact of new guidelines on salvage therapy. They also explore emerging treatments for non-muscle invasive bladder cancer (NMIBC), as well as the evolving role of systemic immunotherapies and advanced genomic testing. To wrap up, the urologists offer detailed analyses and their expert opinions on how these developments could transform patient care in the field of urologic oncology.

---

TIMESTAMPS

00:00 - Introductions
03:06 - Prostate Cancer Screening Insights
10:10 - Advancements in MRI and Biomarkers
18:22 - Transperineal vs. Transrectal Prostate Biopsy
27:18 - New Guidelines for Bladder Cancer Treatment
30:57 - Innovative Drug Delivery Systems
32:36 - Gene Therapy and Immunotherapy Advances
40:11 - Concluding Thoughts and Future Prospects

---

RESOURCES

Decipher Prostate Genomic Classifier by Veracyte:
​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/